Report from SNM: PET/CT helps monitor status of Crohn’s disease
Results from a Belgian study suggest that PET/CT should help supplement endoscopy for assessing the clinical status of Crohn’s disease, an inflammatory bowel disease that affects up to two million people in the U.S., mainly young adults.
Results from a Belgian study suggest that PET/CT should help supplement endoscopy for assessing the clinical status of Crohn's disease, an inflammatory bowel disease that affects up to two million people in the U.S., mainly young adults.
The trial, presented Monday at the 2007 Society of Nuclear Medicine meeting in Washington, DC, found that FDG-PET/CT accurately tracks the nature, frequency, intensity of Crohn's disease, according to lead investigator Dr. Roland Hustinx, head of nuclear medicine at the University Hospital of Liège. As disease status changes, proper therapy must be adjusted.
"PET/CT can answer the major question: What is the activity of the disease?" he said.
In a prospective trial involving 22 Crohn's disease patients, PET/CT detected 100% of the deep ulcers and strictures characteristic of severe endoscopic lesions. Noncontrast CT was most useful for localizing the lesions. Although severe type 3 and 4 endoscopic lesions were more frequently located in segments with bowel thickening, logistic regression analysis revealed that only the segment SUVmax analysis of FDG uptake was significantly associated with the lesions (p = 0.0002).
Overall, FDG-PET/CT detected 35 of 48 endoscopically affected segments for a sensitivity rate of 72.9%.
Patients will probably welcome PET/CT in place of gold standard ileocolonoscopy for monitoring Crohn's disease. The endoscopic exam surveying the large bowel and ileum is costly and can be physically unpleasant, Hustinx said. PET/CT is relatively simple, fast, and free of side effects.
Hustinx recommends PET/CT to screen Crohn's disease patients who require ileocolonoscopy.
"If the PET/CT is positive, the doctor should confirm the results using endoscopy. If the PET/CT is negative, there would be no need for the endoscopy, given the high negative predictive value of the technique," he said.
For more information from the Diagnostic Imaging archives:
Report from ECR: Hardware, software advances give fMRI a place in abdominal imaging
CT beats fluoroscopy for Crohn's disease
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
